The present study was undertaken to determine the effects of exogenous porcine somatotropin (pST) on IGF-I gene expression in liver, skeletal muscle (longissimus dorsi), and S.C. adipose tissue of growing pigs. Twenty prepubertal gilts = 60 kg BW) were allotted to four treatment groups ( n = 5 1 and treated with either 0, 35, 70, or 140 pgkg BW of recombinantly derived pST by daily i.m. injection for 7 d. Serum concentrations of IGF-I were determined by RIA and IGF-I mRNA levels were determined by direct counting of individual samples on slot blots. Administration of pST increased IGF-I concentration in serum. This was accompanied by significant increases ( P < .05) in IGF-I mRNA abundance in liver and S.C. adipose tissue; the effects were maximal at the lowest dose of pST. Insulin-like growth factor I mRNA levels were increased 2.5-and 4.5-fold, respectively. Levels of IGF-I mRNA were very low in longissimus muscle and were unaffected by administration of pST. When expressed as picograms of mRNN10 pg of total RNA, IGF-I mRNA levels were highest in S.C. adipose tissue. Levels of IGF-I mRNA were 1.9-fold higher in S.C. adipose tissue than in liver of control animals, and pST administration increased this difference to 3.2-fold. Our results suggest that 1 ) the effects of pST administered by daily i.m. injection on IGF-I gene expression in pigs are tissue-specific and 2 ) the stimulatory effects of pST administered in this manner on muscle growth in pigs are not associated with increased expression of the IGF-I gene in skeletal muscle.
Introduction
Somatotropin ( ST) is the primary growth-promoting hormone in postnatal vertebrates, and IGF-I has been shown to mediate many of the somatogenic effects of ST (Daughaday et al., 1972; Froesch et al., 1985; Isaksson et al., 1988) . In the rat, ST-dependent IGF-I synthesis has been demonstrated in a number of tissues, suggesting that locally synthesized IGF-I may account for some of the somatogenic effects of ST via autocrine/paracrine mechanisms (D'Ercole et al., 1984; Lund et al., 1986) . Subsequent studies have provided more definitive evidence to indicate that the 'This work was supported in part by USDA Grants 2Current address: Dept. of Cell Biol., Baylor College of Medicine, 3T0 whom correspondence should be addressed: 301 W.L. Received May 6, 1993. Accepted December 17, 1993. 88-37266-3985 and 91-37296-6740 ( t o 
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J. Anim. Sci. 1994. 72:918-924 effects of ST in rats are mediated, in part, by locally synthesized IGF-I (reviewed in Isaksson et al., 1988) .
Administration of pST to growing pigs markedly increases growth rate, feed efficiency, and muscle growth while dramatically reducing fat accretion (Chung et al., 1985; Etherton et al., 1987; Campbell et al., 1988; Evock et al., 1988) . These effects of pST are thought to be mediated in part by increased synthesis of IGF-I (Sillence and Etherton, 1987; Walton and Etherton, 1989; Owens et al., 1990) . However, it has yet to be demonstrated whether or not ST increases IGF-I expression in as broad a range of tissues in pigs as in rats. Grant et al. (1991) recently reported that treatment of growing pigs with pST increased levels of IGF-I mRNA in liver but not in skeletal muscle, suggesting that the trophic effects of pST on skeletal muscle are not due to increased local expression of IGF-I. However, these researchers administered only a modest dose of pST (Le., approximately 50 pgkg BW-l.d-l), and they observed no significant effects of pST on muscle weight. In addition, the effects of pST on IGF-I expression in other nonhepatic tissues were not reported. Thus, the objective of this experiment was to determine the effects of pST administered across a range of doses known to improve pig growth performance (see Etherton et al., 1987; Evock et al., 1988) on the expression of IGF-I mRNA in liver, skeletal muscle, and S.C. adipose tissue of growing pigs. In addition to liver, skeletal muscle and adipose tissue were chosen for investigation of the effects of pST in individual tissues because they are affected markedly by pST, and they are the primary determinants of the economic value of pigs reared for meat production.
Materials and Methods
Materials. Recombinantly derived pST and bovine IGF-I were donated by the Monsanto Go., St. Louis, MO (Robert Collier and Tom Kasser). Chemicals were purchased from Fluka, Switzerland and Sigma, St. Louis, MO. Restriction endonucleases and bacteriophage RNA polymerases were purchased from Boehringer Mannheim, Indianapolis, IN. Agarose was purchased from Bio-Rad, Richmond, CA. Genescreen membrane and 32P-labeled nucleotides were purchased from NEN, Boston, MA. X-ray film (X-OMAT AR) and developer were purchased from Eastman Kodak, Rochester, NY.
Animals and Experimental Protocol. Twenty prepubertal gilts (approximately 60 kg BW and 120 d of age) were randomly allotted to one of four treatment groups and penned in groups of four. Gilts were given ad libitum access to a corn-soybean mealbased diet supplemented with .5% crystalline lysine (Evock et al., 1988) . Gilts were treated with either vehicle or recombinantly derived pST (35, 70, or 140 pg/kg BW) by daily i.m. injection at 0900 for 7 d. One to four hours after the last pST injection, gilts were killed by exsanguination at the University Meats Laboratory. At this time, blood and samples of liver, S.C. adipose tissue (overlying the longissimus muscle between the first through the fifth ribs) and skeletal muscle (longissimus muscle overlying the first through the fifth ribs) were quickly obtained (within 5 min of death). Tissue samples were homogenized in a guanidinium thiocyanate denaturing solution (Chomczyinski and Sacchi, 1987 ) with a polytron tissue homogenizer and stored at -70°C until isolation of total RNA. Serum was prepared and stored at -20°C.
IGF-I RIA. Iodination of IGF-I and the IGF-I RIA were performed as described previously (Evock et al., 1988) .
R N A Isolation and Analysis. Total RNA was prepared from tissue homogenates as described previously (Chomczyinski and Sacchi, 1987) . For S.C. adipose tissue, the extraction was modified to increase the yield of RNA (Louveau et al., 1991) . Hybridization conditions were established by Northern blot analyses of samples of total RNA pooled within treatment. Subsequently, individual samples of total RNA were analyzed in triplicate (i.e., 10, 5.0, and 2.5 pg of total RNA) for IGF-I mRNA. Prehybridization and hybridization solutions consisted of 50% (vol/vol) deionized formamide, 5x SSPE ( l x SSPE = 150 mM NaCl, 10 mM sodium phosphate [pH 7.41, 1 mM EDTA), 5x Denhardt's solution (5x Denhardt's = .l% [wt/voll BSA, .l% [wt/voll polyvinylpyrrolidone, .l% Ficoll) , 1% (wt/vol) SDS, 10% (wt/vol) dextran sulphate, 200 pg/mL salmon sperm DNA. All hybridizations were carried out in a Hybaid hybridization oven (National Labnet Go., Woodbridge, NJ).
A 580-bp pig IGF-I cDNA (Tavakkol et al., 1988 ) subcloned into the pGEM-1 vector (Promega, Madison, WI) was generously provided by Frank Simmen (University of Florida, Gainesville). 32P-labeled antisense IGF-I RNA probe was synthesized using SP6 RNA polymerase and [32PlCTP (400 Ci/mmol). Sense strand IGF-I mRNA was synthesized and used to construct a standard curve for estimating the quantity of IGF-I mRNA in total RNA samples. Yeast tRNA ( 10 pg 1 was used to assess background hybridization.
After prehybridization at 65°C for 2 h, hybridizations with the antisense IGF-I RNA probe ( 2 x lo5 cpml mL) were performed at 65°C for approximately 16 h. Membranes were subsequently washed sequentially for 3 x 15 min in l x SSPE, 1% (wt/vol) SDS at 65°C and 2 x 30 min in .lx SSPE, .l% SDS at 60°C. Slot blots were then counted for 1,000 min in a Betascope model 603 blot analyzer (Betagen, Waltham, MA). Total counts were linearly related to the mass of IGF-I mRNA over a range of 0 to 50 pg. The mass of IGF-I mRNA (pg/lO pg of total RNA) in individual samples of total RNA was then estimated by comparison with counts obtained for known quantities of IGF-I sense strand RNA. An adjustment for the discrepancy between the size of the sense strand IGF-I standard and the size of the predominant IGF-I mRNA in vivo (i.e., .6 vs 1 kb; Tavakkol et al., 1988) was used in calculating IGF-I mRNA mass in total RNA samples.
Statistical Analysis. A randomized complete block design with pen as a blocking factor was initially used for statistical analyses. Because the effect of pen was not significant for any of the parameters evaluated, data were subsequently analyzed by one-way ANOVA using dose of pST as the main effect. Comparisons between treatment means were performed using Tukey's test when the main effect was significant. All statistical analyses were conducted using Minitab statistical analysis software for IBM PCs (Minitab, State College, PA).
Results
Effects of pST on Growth Rate and IGF-I Concentration. Administration of pST for 7 d significantly increased ADG ( P < .05) for the group receiving 70 pg of pST/kg BW daily relative to the control group, and ADG for groups receiving 35 pg or 140 pg of pSTkg BW were intermediate (Figure l a ) . Serum IGF-I concentrations tended to increase as the dose of pST increased; this increase was significant ( P < .05) in the group receiving 140 pg of pST/kg BW/daily relative to the control group (Figure l 
b ) .
Effects of pST on IGF-I mRNA Levels. Northern blot analyses revealed major transcripts of approximately 8.0 and 1.0 kb in all tissues examined ( Figure  2a ). Levels of IGF-I mRNA were 1.9-fold higher in adipose tissue than in liver. Porcine ST increased the abundance of both major transcripts in liver and adipose tissue, but not in longissimus muscle. In addition, two intermediate transcripts of approximately 4.3 and 3.0 kb were detected in S.C. adipose tissue from pST-treated gilts (Figure 2a) . Intermediate IGF-I transcripts were present at appreciably lower levels than either the 8.0-or 1.0-kb transcripts; they were visible only in RNA pools containing the highest levels of IGF-I mRNA (i.e., RNA from S.C. adipose tissue of pST-treated gilts). In addition, qualitative assessment of the relative levels of IGF-I mRNA per unit of total RNA across tissues indicated that liver and longissimus muscle of control gilts contain similar levels of IGF-I mRNA/per unit of total RNA, whereas IGF-I mRNA levels seem to be higher in S.C. adipose tissue (Figure 2a) .
Quantification of IGF-I mRNA abundance was accomplished by slot blot analysis (Figures 3 and 4) . A standard curve for estimation of IGF-I mRNA abundance was constructed by hybridization to known quantities of sense strand IGF-I RNA obtained by transcription in vitro (Figure 3 ) . Treatment with pST elicited significant ( P < -05) increases in IGF-I mRNA levels in liver and S.C. adipose tissue that were maximal (approximately 2.5-and 4.5-fold, respectively at the lowest dose of pST (i.e., 35 pg.kg BW-l.d-l). The abundance of IGF-I mRNA in longissimus muscle was not increased ( P > .lo) by any dose of pST.
Discussion
In this study we observed that IGF-I concentrations in serum tended to increase as the dose of pST increased, as would be expected. Average daily gain, however, was increased maximally in the group receiving 70 pgkg BW daily of recombinant pST relative to the control group; ADG for the groups receiving 35 and 140 pg of pSTkg BW daily were intermediate. Thus, the dose-response for pST's effect on serum IGF-I concentration seems to differ from that for growth parameters. The short treatment duration of 7 d employed in this study could have contributed to this discrepancy. We have previously shown that treatment with pST for 7 d is sufficient for determining the effects on serum concentrations of IGF-I and IGF binding protein and glucose metabolism in S.C. adipose tissue (Sillence and Etherton, 1987; Magri et al., 1990; Coleman and Etherton, 19911 , but 7 d may be too short a time to evaluate the effects of pST on growth and carcass composition. We have previously observed in extended studies that pST elicits dose-dependent effects on growth performance and carcass composition that are paralleled by an increase in serum IGF-I concentration up to a daily dose of pST of approximately 70 pgkg BW (Etherton et al., 1987) . Conversely, doses of pST greater than 70 pglkg BW daily elicit no further increase in growth rate even though serum IGF-I concentrations continue to increase Sillence and Etherton, 1987) . Interestingly, we observed that the effect of pST on IGF-I mRNA levels in liver and subcutaneous adipose tissue, vs serum IGF-I concentrations, more closely resembled that for ADG, suggesting that the effects of pST on expression of target genes may parallel animal performance more closely than do serum concentrations. However, studies of longer duration are needed in which the effects of pST on growth and carcass composition can be fully manifested and then related to parallel measurements of IGF-I gene expression to address this point definitively.
i.m. injection elicited approximately a 2.5-fold increase LIVER in the relative abundance of hepatic IGF-I mRNA, ADIPOSE TISSUE with no concomitant increase in IGF-I mRNA in SKELETAL MUSCLE skeletal muscle, suggesting that the effects of pST in this type of treatment regimen are not due to increased IGF-I expression in skeletal muscle. However, these researchers administered only a modest dose of pST ( -50 pgkg BW-l.d-l), and they observed no significant effects of pST on muscle weight. Thus, our primary objective in this study was to determine the effects of pST on IGF-I mRNA abundance over a It is our perspective that the increase in serum IGF-I concentrations observed with increasing doses of pST is due in part to the effects of pST on serum IGFbinding proteins ( IGFBP). The fact that IGF-I/ IGFBP complexes account for virtually all the circulating IGF-I in growing pigs (Evock et al., 1989) suggests that the effects of pST on IGFBP levels may influence serum IGF-I concentrations significantly. It is clear that the 150-kDA IGFBP-3/IGF/ALS complex has a circulating half-life severalfold that of other IGFBP/IGF complexes that circulate at approximately 40 kDa (Baxter and Martin, 1989) , suggesting that significant changes in the composition of the circulating IGFBP pool would alter the half-life of circulating IGF. In this regard we have previously reported that pST treatment elicits dose-dependent increases in serum IGFBP-3 and dose-dependent decreases in serum IGFBP-2 (Coleman and Etherton, 1991) . Because IGFBP-2 and IBFBP-3 account for the majority of the circulating IGFBP activity in growing pigs (Coleman and Etherton, 1991; Lee et al., 19911 , it is our opinion that the extended range of the doseresponse for pST's effect on serum IGF-I concentration is likely due to the combined effects of pST treatment on synthesis of IGF-I, IGFBP-2, and IGFBP-3. Grant et al. (1991) recently reported that administration of pST to young, pituitary-intact pigs by daily range of doses that have previously been shown to encompass the full dose-response for pST's effects on pig growth performance . Our findings in this study essentially corroborate those of Grant et al. (1991) with regard to liver and skeletal muscle, and thus we conclude that the effects of pST administered by daily i.m. injection on skeletal muscle are not due t o increased local expression of IGF-I. In addition, this response contrasts markedly with that in rats; numerous studies have indicated that locally synthesized IGF-I is at least partly responsible for mediating the effects of ST in rats (see Isaksson et al., 1988 for review) . Therefore, it is our perspective that the rat may have limited utility as a model for ST/ IGF-I physiology in pigs.
In addition to the pST-induced increase in IGF-I mRNA in liver, we also observed a marked increase in IGF-I mRNA abundance in S.C. adipose tissue of pSTtreated gilts. Wolverton et al. ( 1992) have previously reported that pST increases IGF-I mRNA abundance in S.C. adipose tissue of growing pigs. In addition, Gaskins et al. (1990) have shown that pST increases IGF-I mRNA in cultures of porcine preadipocytes, and Vikman et al. (1991) have recently demonstrated that ST increases IGF-I expression in isolated rat adipocytes. Thus, it was not surprising that we also observed increased IGF-I mRNA in S.C. adipose tissue of pST-treated gilts in the present study. The biological significance of this effect in S.C. adipose tissue remains unclear, although we have found that IGF-I does not mimic the insulin antagonistic effects of pST in 48-h cultures of pig S.C. adipose tissue explants (Donkin et al., 1993) . This suggests that IGF-I does not mediate the inhibitory effects of pST on lipid synthesis in vivo. Another possibility is that STdependent IGF-I expression in pig S.C. adipose tissue may function to induce adipogenic differentiation of preadipocytes (Smith et al., 1988; Ramsay et al., 1989) , as has been suggested for S.C. adipose tissue in humans (Ginsberg-Felner, 198 1). However, because pST reduces lipid accretion (i.e., lipid filling of adipocytes) in S.C. adipose tissue of growing pigs, a putative effect of pST on adipogenic differentiation is not important in the context of understanding how pST alters growth and carcass composition in pigs reared for meat production.
Our observation that pST increased IGF-I mRNA in liver and S.C. adipose tissue, but not in skeletal muscle, indicates that the effects of pST administered by daily i.m. injection on IGF-I expression in pigs are tissue-specific and suggests that the relative roles of endocrine vs locally synthesized IGF-I in mediating the effects of pST may be tissue-specific. Isgaard et al. (1988) have shown that administration of ST to rats in a pulsatile manner is more effective than continuous infusion in increasing levels of IGF-I mRNA in skeletal tissues, suggesting that the pattern of ST administration may be a factor governing whether or not one observes a tissue-specific response. Nonetheless, we and others have clearly demonstrated that administration of pST to young pigs via daily i.m. injection (i.e., bolus injection) elicits marked stimulatory effects on muscle growth (Campbell et al., 1988; Evock et al., 1988) . Thus, future studies on ST receptors in these tissues may lead to strategies for targeting and(or) potentiating the effects of pST.
It could be argued that we did not observe an increase in IGF-I mRNA in skeletal muscle because the kinetics of increased transcription of the IGF-I gene and(or) turnover of IGF-I mRNA differed between skeletal muscle and 1iverh.c. adipose tissue. However, our opinion is that this scenario is unlikely because even though Grant et al. ( 1991) sampled 24 h after the last pST injection vs 1 to 4 h in the present study, our observations parallel theirs with regard to the effects of pST on IGF-I mRNA abundance in liver vs skeletal muscle. Thus, a pST-induced increase in IGF-I mRNA in skeletal muscle would have to have been evident only after a period of more than 4 h after injection, and IGF-I mRNA levels would have to have returned to control levels prior to 24 h following the last pST injection (i.e., later than we observed an effect in liver and S.C. adipose tissue in the present study, but prior to when Grant and coworkers observed a significant effect on hepatic IGF-I mRNA levels) for both our groups not to have observed an effect. To our knowledge the kinetics of IGF-I mRNA inductiodturnover in ST-treated animals that are pituitary-intact have not been reported, but Isgaard et al. (1989) have previously reported that a single bolus injection of ST in hypophysectomized rats resulted in an up-regulation of IGF-I mRNA in skeletal muscle that was significantly greater than in controls after 1 h, maximal after 6 h, and remained significantly elevated 24 h after injection. Thus, although it is possible that our sampling strategy contributed to experimental error (i.e., variability), it is very unlikely that an effect of pST on IGF-I mRNA levels in skeletal muscle would not have been detected either by us in the present study or by Grant et al. (1991) . In addition, because we observed no further increase in IGF-I mRNA doses of pST greater than 35 pg/kg BW daily, it is our opinion that the approximately 50 pgkg BW dose of pST administered by Grant et al. ( 199 1) was sufficient to increase IGF-I mRNA in all pST-responsive tissues.
Our results in control gilts suggest that young growing gilts express similar amounts of IGF-I mRNA in liver and skeletal muscle, with S.C. adipose tissue being relatively enriched in IGF-I mRNA. Moreover, this observation implies that IGF-I derived from nonhepatic origins constitutes a significant portion of the IGF-I pool in growing pigs. Lee et al. ( 1993 j have previously reported that young pigs express similar amounts of IGF-I mRNA in liver and nonhepatic tissues (including skeletal muscle j. In contrast, rats express much higher levels of IGF-I mRNA in liver than in skeletal muscle. Moller et al. (1991) recently quantified IGF-I mRNNcel1 in liver, skeletal muscle, and adipose tissue of adult rats and humans and found that adult rats express significantly more IGF-I mRNNcel1 in liver than in nonhepatic tissues, whereas adult humans express an approximately equal number of IGF-I mRNA molecules/cell across these tissues. The methodology that we used for quantifying the relative abundance of IGF-I mRNA in this study does not allow us to express IGF-I mRNA on a per-cell basis. Nonetheless, our results and those of others (Lee et al., 1993) suggest that domestic pigs might be a more appropriate model than rats for relating these aspects of ST physiology to humans and, conversely, that rats may not be a good model for pigs.
In summary, our results indicate that administration of pST to growing pigs elicits tissue-specific effects on levels of IGF-I mRNA. Our results also provide further support for the idea that IGF-I derived from circulation, although not necessarily of hepatic origin, mediates the effects of exogenous pST on skeletal muscle growth in growing pigs.
Implications
The effects of administering pST by daily i.m. injection on IGF-I expression in target tissues of gilts were examined to gain further insight into the mechanisms underlying the marked effects that pST has on growth performance and carcass composition. Results indicate that this treatment regimen elicits tissue-specific effects on IGF-I expression. In addition, results provide evidence that heterogeneity of function may exist among ST receptors in the tissues examined. It is our perspective that the nature of pST receptor function in pig tissues is an important area of future research that may lead to the development of new strategies for targeting the effects of pST.
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